PATENT CLAIM ANALYSIS

Application Number: 15742391
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "771000"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases, containing a maple leaf extract as an active ingredient. The maple leaf extract exhibits an effect of inhibiting hyperemia in the eyeball in which hyperemia has been induced and an effect of inhibiting angiogenesis in the eyeball in which corneal damage has been induced, thus being effectively used in a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases.

Claim (Index 5):
The method of  claim 1 , wherein the conjunctival disease is any one selected from the group consisting of conjunctivitis, pingueculitis, and pterygium.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.86364
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15509532', '15453417', '15519497', '15700735', '14829789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6980679047711505
- 35 USC 102 Novelty (BERT): 0.4916515341346825
- Combined Prediction Score: 0.6774262677075038
- Mean Citation Score: 147.644178
- Max Citation Score: 150.20729
- Similarity Product: 96.68764524875525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test